BIOG.L Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 май 2024 @ 14:19):

Stats
Объем за сегодня	23 334.00
Средний объем	71 459.00
Рыночная капитализация	330.71M
EPS	£0 ( 2023-11-08 )
Дата следующего отчета о доходах	( £0 ) 2024-06-13
Last Dividend	£0.200 ( 2001-07-04 )
Next Dividend	£0 ( N/A )
P/E	-4.30
ATR14	£6.44 (0.65%)

Объем Корреляция

Длинно: -0.02 (neutral)

Кратко: -0.90 (strong negative)

Signal:(57.636) Neutral

Biotech Growth Trust PLC Корреляция

10 Самые положительные корреляции
AFRN.L	0.952
LXI.L	0.928
LOK.L	0.925
VMUK.L	0.919
ALFA.L	0.917
JMI.L	0.917
BNKS.L	0.916
UTL.L	0.916
SDIP.L	0.914
NOG.L	0.911

10 Самые отрицательные корреляции
GLB.L	-0.947
UD04.L	-0.925
AMC.L	-0.918
UAI.L	-0.917
7DIG.L	-0.916
INX.L	-0.912
FCCN.L	-0.907
BVIC.L	-0.905
UNG.L	-0.905
TFG.L	-0.903

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Biotech Growth Trust PLC Корреляция - Валюта/Сырье

-0.47
( neutral )

-0.63
( weak negative )

-0.57
( weak negative )

-0.21
( neutral )

0.45
( neutral )

0.05
( neutral )

Biotech Growth Trust PLC Финансовые показатели

Annual	2022
Выручка:	£-37.65M
Валовая прибыль:	£-37.65M (100.00 %)
EPS:	£-1.030

FY	2022
Выручка:	£-37.65M
Валовая прибыль:	£-37.65M (100.00 %)
EPS:	£-1.030

FY	2022
Выручка:	£-209.71M
Валовая прибыль:	£-209.71M (100.00 %)
EPS:	£-4.88

FY	2021
Выручка:	£222.06M
Валовая прибыль:	£0.00 (0.00 %)
EPS:	£4.44

Financial Reports:

No articles found.

Biotech Growth Trust PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Biotech Growth Trust PLC Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.02 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£0.600	1998-07-13
Last Dividend	£0.200	2001-07-04
Next Dividend	£0	N/A
Payout Date	2001-07-30
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	£1.200	--
Avg. Dividend % Per Year	0.00%	--
Score	0.26	--
Div. Sustainability Score	2.02
Div.Growth Potential Score	0
Div. Directional Score	0.0835	--

Next Divdend (Est)
(2025-01-20)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.26

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
1998	£0.600	0.62%
1999	£0.400	0.57%
2000	£0	0.00%
2001	£0.200	0.10%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
STS.L	Dividend Knight	2023-10-05	Quarterly	38	1.48%
JUST.L	Dividend Royal	2023-08-24	Annually	11	93.97%
CCEP.L	Dividend Knight	2023-05-11	Annually	6	1.61%
QQ.L	Dividend Knight	2023-07-27	Semi-Annually	19	1.52%
GFTU.L	Dividend Knight	2023-09-21	Semi-Annually	15	2.21%
ALFA.L	Dividend King	2023-09-14	Semi-Annually	5	3.78%
TORO.L	Dividend King	2023-08-10	Quarterly	9	8.28%
LWI.L	Dividend King	2023-06-29	Quarterly	53	2.58%
CRDA.L	Dividend Knight	2023-08-31	Semi-Annually	32	0.95%
RTC.L	Dividend Royal	2023-08-03	Annually	27	157.11%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	1.050	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	-0.299	1.200	-9.95	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.295	1.500	-4.39	-6.58	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.298	0.800	-3.51	-2.81	[1 - 3]
quickRatioTTM	0.298	0.800	-2.95	-2.36	[0.8 - 2.5]
cashRatioTTM	0.212	1.500	9.93	10.00	[0.2 - 2]
debtRatioTTM	0.0742	-1.500	8.76	-10.00	[0 - 0.6]
interestCoverageTTM	-176.03	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.159	2.00	-0.0530	-0.106	[0 - 30]
freeCashFlowPerShareTTM	-0.159	2.00	-0.0795	-0.159	[0 - 20]
debtEquityRatioTTM	0.0780	-1.500	9.69	-10.00	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	1.044	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.260	1.000	-2.56	-2.56	[0.2 - 2]
assetTurnoverTTM	-0.284	0.800	-5.23	-4.18	[0.5 - 2]
Total Score				2.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-3.95	1.000	-0.500	0	[1 - 100]
returnOnEquityTTM	-0.295	2.50	-2.82	-6.58	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.159	2.00	-0.0530	-0.159	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.159	2.00	-0.0530	-0.106	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-5.00	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0679	1.000	-0.803	0	[0.1 - 0.5]
Total Score				-1.857

Biotech Growth Trust PLC

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.